ATF3 key role in breast cancer metastasis

ATF3 Has Key Role in Host Cell Enhancement of Breast CA Mets
ATF3 Has Key Role in Host Cell Enhancement of Breast CA Mets

(HealthDay News) -- Activating transcription factor 3 (ATF3), at the center of the cellular adaptive response network, plays a key role in host cell enhancement of breast cancer metastasis, according to a study published in the July 1 issue of the Journal of Clinical Investigation.

Chris C. Wolford, from The Ohio State University in Columbus, and colleagues investigated the molecular mechanisms underlying host response to cancer signals in the development of breast cancer.

The researchers found that ATF3 plays an important role in enhancing breast cancer metastasis in host cells. In patient tumor samples, ATF3 expression in stromal mononuclear cells, but not cancer epithelial cells, correlated with worse clinical outcomes and independently predicted breast cancer death. In mouse models, breast cancer metastasis was less efficient in Aft3-deficient versus wild-type mice. Fewer lung metastases were seen in mice with myeloid cell-selective knock out of Atf3. An ATF3-regulated gene signature was identified that could differentiate human tumor stroma from distant stroma, and could predict clinical outcomes in gene profiling analyses of macrophages from mouse tumors.

"In conclusion, we identified ATF3 as a regulator in myeloid cells that enhances breast cancer metastasis and has predictive value for clinical outcomes," the authors write.

Full Text

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs